Search results for "PARTICLES"

showing 10 items of 8085 documents

Antibacterial drug release from a biphasic gel system: Mathematical modelling

2019

Bacterial infections represent an important drawback in the orthopaedic field, as they can develop either immediately after surgery procedures or after some years. Specifically, in case of implants, they are alleged to be troublesome as their elimination often compels a surgical removal of the infected implant. A possible solution strategy could involve a local coating of the implant by an antibacterial system, which requires to be easily applicable, biocompatible and able to provide the desired release kinetics for the selected antibacterial drug. Thus, this work focusses on a biphasic system made up by a thermo-reversible gel matrix (Poloxamer 407/water system) hosting a dispersed phase (…

DrugMaterials sciencemedia_common.quotation_subjectVancomycin HydrochloridePharmaceutical SciencePoloxamer02 engineering and technologyantibacterial drugengineering.material030226 pharmacology & pharmacyDiffusion03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMicro-particleCoatingVancomycinAntibacterial drugmedicineAntibacterial drugmedia_commonGelMathematical modellingReproducibility of ResultsMicro-particlesModels Theoretical021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationKineticsPLGAchemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoantibacterial drug; Gels; Mathematical modelling; Micro-particles; Orthopaedic implantsPoloxamer 407engineeringOrthopaedic implantsDelivery systemImplant0210 nano-technologyGelsmedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies

2009

The prospect of improved cancer therapy using Solid Lipid Nanoparticles (SLNs) as drug delivery system is promising. Sev- eral obstacles frequently encountered with anticancer compounds, such as poor drug solubility, are overcome by delivering them using SLN. Moreover, the intravenous administration of drugs into SLNs can potentially enhance drug blood circulation time and improve drug per- formance by inducing accumulation into tumours by enhanced permeability and retention (EPR) effect. This paper deals with the devel- opment of SLN containing nimesulide, a non-steroidal anti-inflammatory drug with antitumour effect and low solubility in water. Here, SLNs carrying nimesulide were prepared…

DrugMaterials sciencemedia_common.quotation_subjectsolid lipid nanoparticles nimesulide drug deliveryBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringPharmacologyIn vitroSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSolid lipid nanoparticleDrug deliveryZeta potentialmedicineSolubilityCytotoxicityBiotechnologymedia_commonNimesulidemedicine.drugCurrent Nanoscience
researchProduct

Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity.

2005

Solid lipid nanoparticles (SLNs) containing tamoxifen, a nons- teroidal antiestrogen used in breast cancer therapy, were prepared by microemulsion and precipitation techniques. Tamoxifen loaded SLNs seem to have dimensional properties useful for parenteral administration, and in vitro plasmatic drug release studies demon- strated that these systems are able to give a prolonged release of the drug in the intact form. Preliminary study of antiproliferative ac- tivity in vitro, carried out on MCF-7 cell line (human breast cancer cells), demonstrated that SLNs, containing tamoxifen showed an antitumoral activity comparable to free drug. The results of char- acterization studies and of in vitro …

DrugOctanolsMaterials scienceTime FactorsAntineoplastic Agents Hormonalmedia_common.quotation_subjectPharmaceutical SciencePharmacologyColloidal Drug Delivery Systems Solid Lipid Nanoparticles (SLNs) TamoxifenBreast cancerDrug StabilityCell Line TumorSolid lipid nanoparticlemedicineHumansParticle Sizeskin and connective tissue diseasesmedia_commonCell ProliferationDrug CarriersWaterGeneral MedicineHydrogen-Ion Concentrationmedicine.diseaseAntiestrogenLipidsIn vitroNanostructuresbody regionsTamoxifenSolubilityDelayed-Action PreparationsCancer cellDrug carrierTamoxifenmedicine.drugDrug delivery
researchProduct

Solid and Semisolid Innovative Formulations Containing Miconazole-Loaded Solid Lipid Microparticles to Promote Drug Entrapment into the Buccal Mucosa

2021

The currently available antifungal therapy for oral candidiasis (OC) has various limita- tions restricting its clinical use, such as short retention time, suboptimal drug concentration and low patients compliance. These issues could be overcome using micro or nanotechnology. In par- ticular, solid lipid microparticles (SLMs) resulted as a particularly promising penetration enhancer carrier for lipophilic drugs, such as the antifungal miconazole (MCZ). Based on these considera- tions, cetyl decanoate (here synthesized without the use of metal catalysis) was employed together with 1-hexadecanol to prepare MCZ-loaded SLMs. These resulted in a powder composed of 45–300 µm diameter solid spheric…

Drugbuccal filmmedia_common.quotation_subjectPharmaceutical SciencemiconazoleBuccal mucosaArticleDosage formbuccal gelEntrapmentPharmacy and materia medicaoral candidiasismedicineex vivo studiemedia_commonChromatographycetyl decanoateChemistryex vivo studiesBuccal administrationPermeationoral candidiasiRS1-441mucosal deliverySettore CHIM/09 - Farmaceutico Tecnologico Applicativopenetration enhancersolid lipid microparticlebuccal mucosasolid lipid microparticlesMiconazoleEx vivomedicine.drugPharmaceutics
researchProduct

Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug.

2018

Abstract Atenolol is a drug widely used for the treatment of hypertension. However, the great drawback it presents is a low bioavailability after oral administration. To obtain formulations that allow to improve the bioavailability of this drug is a challenge for the pharmaceutical technology. The objective of this work was to increase the rate and extent of intestinal absorption of atenolol as model of a low permeability drug, developing a double technology strategy. To increase atenolol permeability an ion pair with brilliant blue was designed and the sustained release achieved through encapsulation in polymeric nanoparticles (NPs). The in vitro release studies showed a pH-dependent relea…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technology030226 pharmacology & pharmacyIntestinal absorptionPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivoOral administrationmedicineAnimalsRats WistarAntihypertensive Agentsmedia_commonChromatographyChemistryBenzenesulfonates021001 nanoscience & nanotechnologyAtenololControlled releaseBioavailabilityPLGADrug LiberationAtenololIntestinal AbsorptionNanoparticles0210 nano-technologymedicine.drugInternational journal of pharmaceutics
researchProduct

Nanocarriers for respiratory diseases treatment: Recent advances and current challenges

2014

Pulmonary delivery of locally-acting drugs encapsulated in nanocarriers provides several advantages for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, cystic fibrosis, tuberculosis and lung cancer. These advantages include, among others, sustained drug delivery to the lungs, reduced therapeutic dose and improved patient compliance. The aim of this review is to give an updated overview on recent advances recorded in the last few years in this field as well as on the major challenges still existing and that remain to be overcome before any clinical application. After an outline on the cellular and extracellular barriers affecting drug delivery to…

Drugmedicine.medical_specialtymedia_common.quotation_subjectpulmonary deliveryAntitubercular AgentsMicrobial Sensitivity TestsGene deliveryPharmacologyCystic fibrosisTherapeutic indexDrug DiscoverymedicineAnimalsHumansTuberculosisIntensive care medicinemedia_commonDrug CarriersLungrespiratory diseasesbusiness.industryMycobacterium tuberculosisGeneral Medicinemedicine.diseaseinhalation of polymeric- and lipid-based nanocarriermedicine.anatomical_structurelung targetingTargeted drug deliveryDrug deliverymucus penetrationNanoparticlesNanocarriersbusinessDefense mechanism
researchProduct

OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis

2016

Background Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease affecting joints due to the persistent synovial tissue inflammation. RA treatment has dramatically evolved in the last 20 years due to the production of biological Disease Modifying Antirheumatic Drugs (bDMARDs). However, side effects and the high costs of biological drugs are holding back their widespread usage. Moreover, some patients fail to respond to bDMARDs, for all of these reasons, DMARDs remains the main desired strategy for the treatment of RA, and Methotrexate (MTX) is still the “anchor” drug to treat RA. A successful treatment depends also on the early diagnosis, treating patients as soon as possible …

Drugrheumatoid arthritisInflammatory arthritismedia_common.quotation_subjectImmunologyArthritisInflammationPharmacologyGeneral Biochemistry Genetics and Molecular BiologymethotrexateRheumatologyIn vivomedicineImmunology and Allergyrheumatoid arthritis; nanoparticles; collagen induced arthritis; methotrexatemedia_commonbusiness.industrynanoparticleTherapeutic effectrheumatoid arthritimedicine.diseasecollagen induced arthritiscollagen induced arthritiRheumatoid arthritisImmunologyMethotrexatenanoparticlesmedicine.symptombusinessmedicine.drug
researchProduct

Exploring the mass surface near the rare-earth abundance peak via precision mass measurements at JYFLTRAP

2019

The JYFLTRAP double Penning trap at the Ion Guide Isotope Separator On-Line (IGISOL) facility has been used to measure the atomic masses of 13 neutron-rich rare-earth isotopes. Eight of the nuclides, $^{161}$Pm, $^{163}$Sm, $^{164,165}$Eu, $^{167}$Gd, and $^{165,167,168}$Tb, were measured for the first time. The systematics of the mass surface has been studied via one- and two-neutron separation energies as well as neutron pairing-gap and shell-gap energies. The proton-neutron pairing strength has also been investigated. The impact of the new mass values on the astrophysical rapid neutron capture process has been studied. The calculated abundance distribution results in a better agreement w…

EFFICIENCYrare and new isotopesastrofysiikkanuclear astrophysicsNuclear Theoryr processFOS: Physical sciencesnucl-ex01 natural sciences7. Clean energybinding energy and massesIonPENNING TRAPS0103 physical sciencesNuclear Physics - ExperimentNeutronNuclideIONNuclear Experiment (nucl-ex)Nuclear Experiment010306 general physicsNuclear ExperimentDETECTORPhysicsScience & TechnologySTABILITYIsotope010308 nuclear & particles physicsPhysicsR-PROCESSRAMSEY METHODPenning trapnuclear structure and decaysAtomic massNeutron capturePhysics NuclearSPECTROMETRY13. Climate actionPairingPhysical SciencesELECTRONAtomic physicsydinfysiikkaDECAYPhysical Review C
researchProduct

WCxf: An exchange format for Wilson coefficients beyond the Standard Model

2018

We define a data exchange format for numerical values of Wilson coefficients of local operators parameterising low-energy effects of physics beyond the Standard Model. The format facilitates interfacing model-specific Wilson coefficient calculators, renormalisation group (RG) runners, and observable calculators. It is designed to be unambiguous (defining a non-redundant set of operators with fixed normalisation in each basis), extensible (allowing the addition of new EFTs or bases by the user), and robust (being based on industry standard file formats with parsers implemented in many programming languages). We have implemented the format for the Standard Model EFT (SMEFT) and for the weak e…

EFTSParsing010308 nuclear & particles physicsComputer scienceProgramming languagePhysics beyond the Standard ModelFOS: Physical sciencesGeneral Physics and AstronomyPython (programming language)computer.software_genreFile format01 natural sciencesPartícules (Física nuclear)High Energy Physics - PhenomenologyHigh Energy Physics - Phenomenology (hep-ph)Hardware and ArchitectureData exchangeInterfacing0103 physical sciencesElectroweak scale010306 general physicscomputercomputer.programming_language
researchProduct

Effective Field Theory and Lattice QCD approaches for hard probes in QCD matter

2018

Hard Probes are an essential tool to discover the properties of the quark-gluon plasma created in heavy-ion collisions. The study of hard probes always involves taking into account very different energy scales, and this is precisely the situation in which Effective Fields Theories (EFTs) are useful. EFTs can be used to separate the short-distance and perturbative physics from the long-distance and non-perturbative. This method combined with Lattice QCD evaluations of the long-distance effects can provide accurate and first principles results. In this proceeding, I will report recent advances in this direction. Results from an EFT computation of quarkonium $R_{AA}$ at $\sqrt{s_{NN}}=5.02\,\t…

EFTSPhysicsParticle physics010308 nuclear & particles physicsComputationNuclear TheoryHigh Energy Physics::PhenomenologyFOS: Physical sciencesPlasmaLattice QCDQuarkonium01 natural sciencesHigh Energy Physics - PhenomenologyHigh Energy Physics - Phenomenology (hep-ph)0103 physical sciencesEffective field theory010306 general physicsEnergy (signal processing)QCD matter
researchProduct